Cortés et al. reported that the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) induced apoptosis in all NB cell lines (regardless of MYCN status) and reduced MYCN expression, but changes in MYCN expression levels did not affect the efficacy of SAHA (Cortés et al., 2015). This evidence concerns the gene MYCN and neuroblastoma.